Effect of Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) on Quality of Life in X-Linked Hypophosphatemia (XLH)Mary Denise Ruppe,Xiaoping Zhang,Erik Allen Imel,Thomas Joseph Weber,Mark Klausner,Takahiro Ito,Maria Vergeire,Jeffrey Humphrey,Francis H. Glorieux,Anthony A. Portale,Karl Insogna,Munro Peacock,Thomas O. CarpenterENDOCRINE REVIEWS（2014）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
